2-fluoroethoxy-N-n-propylnorapomorphine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2009
02419822009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Changes in D2-like dopamine (DA) receptor binding in rat brain regions were compared by quantitative in vitro receptor… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1995
1995
We stably expressed a rat D3 receptor cDNA in C6 glioma cells (C6-D3 cells), quantifying receptor expression with the… (More)
Is this relevant?
1993
1993
To better characterize the neuroleptic-like properties of neurotensin, the dose-related effects of the peptide on the following… (More)
Is this relevant?
1990
1990
The effects of intracerebral application of neurotensin on the behavioural responses to peripheral dopamine agonist… (More)
Is this relevant?
1989
1989
Injection of the dopamine (DA) agonist R-(-)-N-n-propylnorapomorphine (NPA; 5-40 micrograms) into anterior ventral striatal sites… (More)
Is this relevant?
1988
1988
Dose-effect curves were obtained for five specific components of stereotyped behavior (locomotor hyperactivity, rearing, sniffing… (More)
Is this relevant?
1986
1986
We administered N-propylnorapomorphine, a potent aporphine-family dopamine (DA) agonist, to schizophrenic patients with active… (More)
Is this relevant?
1984
1984
The D-2 dopamine receptor mediates inhibition of adenylate cyclase in rat intermediate lobe; this receptor is linked to cyclase… (More)
Is this relevant?
1984
1984
Dopamine receptors were localized autoradiographically in the rat spinal cord afterin vitro labelling using3H-N… (More)
  • figure 1
  • table 1
Is this relevant?
1984
1984
The experimental conditions allowing to elicit by administration of dopamine agonists a climbing behavior in rats, apparently… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?